| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.57M | $67.11M | - | |
| COO | 422.8K | $11.03M | - | |
| CFO | 212.2K | $5.54M | - | |
| Dir | 135.2K | $3.53M | - | |
| Dir | 51.1K | $1.33M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 17, 2023 | Marianna Mancini58 | Chief Operating Officer | Sale+OE | 12,500 | $20.00 | $250,000.00 | -4.2% | -21.1% | +246.2% | |
| Apr 13, 2023 | Brian Lian54 | President & CEO | Sale+OE | 79,336 | $18.45 | $1,463,749.20 | -3.3% | -17.3% | +268.5% | |
| Apr 12, 2023 | Greg Zante55 | Chief Financial Officer | Sale+OE | 97,839 | $18.00 | $1,761,310.29 | -39.6% | -9.8% | +299.7% | |
| Apr 3, 2023 | Brian Lian54 | President & CEO | Sale+OE | 243,352 | $17.31 | $4,211,292.40 | -9.8% | -12.1% | +340.2% | |
| Apr 3, 2023 | Greg Zante55 | Chief Financial Officer | Sale+OE | 161,940 | $17.19 | $2,784,218.57 | -52.3% | -12.1% | +340.2% | |
| Mar 29, 2023 | Marianna Mancini58 | Chief Operating Officer | Sale+OE | 237,805 | $15.17 | $3,608,317.00 | -47.6% | -6.9% | +414.8% | |
| May 2, 2022 | Matthew W Foehr71 | Director | Buy | 45,000 | $2.47 | $111,195.00 | +67.9% | +13.4% | +730.0% | |
| Jun 10, 2021 | Matthew W Foehr71 | Director | Buy | 20,000 | $5.69 | $113,800.00 | +43.2% | +17.4% | -60.3% | |
| Aug 26, 2020 | Ligand Pharmaceuticals Inc | 10% Owner | Sell | 164,488 | $8.07 | $1,327,683.70 | -2.7% | - | - | |
| Jun 30, 2020 | Matthew W Foehr71 | Director | Sell | 13,000 | $7.35 | $95,550.00 | -33.1% | - | - |